Ewha Med J.  2024 Apr;47(2):e31. 10.12771/emj.2024.e31.

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration — a Korean translation

• Vandenbroucke JP
• Elm Ev
• Altman DG
• Gøtzsche PC
• Mulrow CD
• Pocock SJ
• Poole C
• Schlesselman JJ
• Egger M
• for the STROBE Initiative

• KMID: 2556320
• DOI: http://doi.org/10.12771/emj.2024.e31

Figure

• 

  *Denominator data missing from one session at which at least 3 attended with cough, 2 recruaited

Reference

References

1. Glasziou P, Vandenbroucke J, Chalmers I. Assessing the quality of research. BMJ. 2004; 328(7430):39–41. DOI: 10.1136/bmj.328.7430.39. PMID: 14703546. PMCID: PMC313908.

2. Funai EF, Rosenbush EJ, Lee MJ, Del Priore G. Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest. 2001; 51(1):8–11. DOI: 10.1159/000052882. PMID: 11150867.

3. Scales CD, Norris RD, Peterson BL, Preminger GM, Dahm P. Clinical research and statistical methods in the urology literature. J Urol. 2005; 174(4 Pt 1):1374–1379. DOI: 10.1097/01.ju.0000173640.91654.b5. PMID: 16145441.

4. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, Kalish LA, et al. Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ. 2004; 329(7471):883. DOI: 10.1136/bmj.38250.571088.55. PMID: 15469946. PMCID: PMC523109.

5. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol. 2005; 161(3):280–288. DOI: 10.1093/aje/kwi042. PMID: 15671260.

6. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007; 4(10):e296. DOI: 10.1371/journal.pmed.0040296. PMID: 17941714. PMCID: PMC2020495.

7. Mihailovic A, Bell CM, Urbach DR. Users’ guide to the surgical literature. Case-control studies in surgical journals. Can J Surg. 2005; 48(2):148–151.

8. Rushton L. Reporting of occupational and environmental research: use and misuse of statistical and epidemiological methods. Occup Environ Med. 2000; 57(1):1–9. DOI: 10.1136/oem.57.1.1. PMID: 10711263. PMCID: PMC1739857.

9. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990; 1(1):43–46. DOI: 10.1097/00001648-199001000-00010. PMID: 2081237.

10. Moonesinghe R, Khoury MJ, Janssens ACJW. Most published research findings are false—but a little replication goes a long way. PLoS Med. 2007; 4(2):e28. DOI: 10.1371/journal.pmed.0040028. PMID: 17326704. PMCID: PMC1808082.

11. Jenicek M. Clinical case reporting in evidence-based medicine. Oxford: Butterworth-Heinemann;1999.

12. Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med. 2001; 134(4):330–334. DOI: 10.7326/0003-4819-134-4-200102200-00017. PMID: 11182844.

13. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med. 2003; 138(1):41–44. DOI: 10.7326/0003-4819-138-1-200301070-00010. PMID: 12513043.

14. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer. 2005; 93(4):387–391. DOI: 10.1038/sj.bjc.6602678. PMID: 16106245. PMCID: PMC2361579.

15. Ioannidis JPA, Gwinn M, Little J, Higgins JPT, Bernstein JL, Boffetta P, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet. 2006; 38(1):3–5. DOI: 10.1038/ng0106-3. PMID: 16468121.

16. Rodrigues L, Kirkwood BR. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol. 1990; 19(1):205–213. DOI: 10.1093/ije/19.1.205. PMID: 2190942.

17. Rothman KJ, Greenland S. Case-control studies. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 93–114.

18. Forand SP. Leukaemia incidence among workers in the shoe and boot manufacturing industry: a case-control study. Environ Health. 2004; 3(1):7. DOI: 10.1186/1476-069X-3-7. PMID: 15339334. PMCID: PMC517727.

19. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med. 2000; 342:1878–1886. DOI: 10.1056/NEJM200006223422506. PMID: 10861324.

20. tzsche PC, Harden A. Searching for non-randomised studies [Internet]. London (UK): Cochrane;c2002. [cited 2007 Sep 10]. Available from. http://www.cochrane.dk/nrsmg.

21. Lohse N, Hansen ABE, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007; 146(2):87–95. DOI: 10.7326/0003-4819-146-2-200701160-00003. PMID: 17227932.

22. American Journal of Epidemiology. Information for authors [Internet]. Oxford (UK): Oxford University Press;c2007. [cited 2007 Sep 10]. Available from. http://www.oxfordjournals.org/aje/for_authors/index.html.

23. Brian Haynes R, Mulrow CD, Huth EJ, Altman DG, Gardner MJ. More informative abstracts revisited. Ann Intern Med. 1990; 113(1):69–76. DOI: 10.7326/0003-4819-113-1-69. PMID: 2190518.

24. Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR, et al. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. CMAJ. 1994; 150(10):1611–1615.

25. Hartley J, Sydes M. Which layout do you prefer? An analysis of readers’ preferences for different typographic layouts of structured abstracts. J Inf Sci. 1996; 22(1):27–37. DOI: 10.1177/016555159602200103.

26. Viner RM, Cole TJ. Adult socioeconomic, educational, social, and psychological outcomes of childhood obesity: a national birth cohort study. BMJ. 2005; 330(7504):1354. DOI: 10.1136/bmj.38453.422049.E0. PMID: 15901644. PMCID: PMC558281.

27. McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, DeChant HK, et al. The “battering syndrome”: prevalence and clinical characteristics of domestic violence in primary care internal medicine practices. Ann Intern Med. 1995; 123(10):737–746. DOI: 10.7326/0003-4819-123-10-199511150-00001. PMID: 7574191.

28. McEvoy SP, Stevenson MR, McCartt AT, Woodward M, Haworth C, Palamar P, et al. Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study. BMJ. 2005; 331(7514):428. DOI: 10.1136/bmj.38537.397512.55. PMID: 16012176. PMCID: PMC1188107.

29. Vandenbroucke JP. Prospective or retrospective: what’s in a name? BMJ. 1991; 302(6771):249–250. DOI: 10.1136/bmj.302.6771.249. PMID: 1998787. PMCID: PMC1668954.

30. Last JM. A dictionary of epidemiology. New York: Oxford University Press;2000.

31. Miettinen OS. Theoretical epidemiology: principles of occurrence research in medicine. New York: Wiley;1985.

32. Rothman KJ, Greenland S. Types of epidemiologic studies. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 74–75.

33. MacMahon B, Trichopoulos D. Epidemiology: principles and methods. 2nd ed. Boston: Little, Brown;1996. DOI: 10.1016/S0033-3506(97)00047-4.

34. Lilienfeld AM. Foundations of epidemiology. New York: Oxford University Press;1976.

35. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995; 332(14):912–917. DOI: 10.1056/NEJM199504063321403. PMID: 7877648.

36. Goodman KJ, O’Rourke K, Sue Day R, Wang C, Nurgalieva Z, Phillips CV, et al. Dynamics of Helicobacter pylori infection in a US–Mexico cohort during the first two years of life. Int J Epidemiol. 2005; 34(6):1348–1355. DOI: 10.1093/ije/dyi152. PMID: 16076858.

37. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer. 1995; 72(2):511–518. DOI: 10.1038/bjc.1995.364. PMID: 7640241. PMCID: PMC2033978.

38. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, Prineas RJ, et al. Transfusion history and cancer risk in older women. Ann Intern Med. 1993; 119(1):8–15. DOI: 10.7326/0003-4819-119-1-199307010-00002. PMID: 8498768.

39. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL. Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol. 2004; 160(7):679–687. DOI: 10.1093/aje/kwh267. PMID: 15383412.

40. Canto JG, Allison JJ, Kiefe CI, Fincher C, Farmer R, Sekar P, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med. 2000; 342(15):1094–1100. DOI: 10.1056/NEJM200004133421505. PMID: 10760310.

41. Metzkor-Cotter E, Kletter Y, Avidor B, Varon M, Golan Y, Ephros M, et al. Long-term serological analysis and clinical follow-up of patients with cat scratch disease. Clin Infect Dis. 2003; 37(9):1149–1154. DOI: 10.1086/378738. PMID: 14557957.

42. Johnson ES. Bias on withdrawing lost subjects from the analysis at the time of loss, in cohort mortality studies, and in follow-up methods. J Occup Environ Med. 1990; 32(3):250–254. DOI: 10.1097/00043764-199003000-00013. PMID: 2319358.

43. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biom Bull. 1946; 2(3):47–53. DOI: 10.2307/3002000. PMID: 21001024.

44. Feinstein AR, Walter SD, Horwitz RI. An analysis of Berkson’s bias in case-control studies. J Chronic Dis. 1986; 39(7):495–504. DOI: 10.1016/0021-9681(86)90194-3. PMID: 3722313.

45. Jick H, Vessey MP. Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol. 1978; 107(1):1–7. DOI: 10.1093/oxfordjournals.aje.a112502. PMID: 623085.

46. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet. 2006; 367(9508):413–418. DOI: 10.1016/S0140-6736(06)68041-0. PMID: 16458766.

47. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, Smith PG, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet. 2004; 364(9438):963–969. DOI: 10.1016/S0140-6736(04)17020-7. PMID: 15364187.

48. Costanza MC. Matching. Prev Med. 1995; 24(5):425–433. DOI: 10.1006/pmed.1995.1069. PMID: 8524715.

49. Stürmer T, Brenner H. Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. Am J Epidemiol. 2002; 155(7):593–602. DOI: 10.1093/aje/155.7.593. PMID: 11914186.

50. Rothman KJ, Greenland S. Matching. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 147–161.

51. Szklo MF, Javier Nieto F. Epidemiology, beyond the basics. Sudbury: Jones & Bartlett Learning;2000. p. p. 40–51.

52. Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971; 25(4):242–244. DOI: 10.1136/jech.25.4.242. PMID: 5160433. PMCID: PMC478665.

53. Gissler M, Hemminki E. The danger of overmatching in studies of the perinatal mortality and birthweight of infants born after assisted conception. Eur J Obstet Gynecol Reprod Biol. 1996; 69(2):73–75. DOI: 10.1016/0301-2115(95)02517-0. PMID: 8902436.

54. Gefeller O, Pfahlberg A, Brenner H, Windeler J. An empirical investigation on matching in published case–control studies. Eur J Epidemiol. 1998; 14(4):321–325. DOI: 10.1023/A:1007497104800. PMID: 9690747.

55. Artama M, Ritvanen A, Gissler M, Isojärvi J, Auvinen A. Congenital structural anomalies in offspring of women with epilepsy: a population-based cohort study in Finland. Int J Epidemiol. 2006; 35(2):280–287. DOI: 10.1093/ije/dyi234. PMID: 16280367.

56. Ebrahim S. Cohorts, infants and children. Int J Epidemiol. 2004; 33(6):1165–1166. DOI: 10.1093/ije/dyh368.

57. Walker M, Whincup PH, Shaper AG. The British Regional Heart Study 1975–2004. Int J Epidemiol. 2004; 33(6):1185–1192. DOI: 10.1093/ije/dyh295. PMID: 15319395.

58. Wieland S, Dickersin K. Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives. J Clin Epidemiol. 2005; 58(6):560–567. DOI: 10.1016/j.jclinepi.2004.11.018. PMID: 15878469.

59. Anderson HR, Atkinson RW, Peacock JL, Sweeting MJ, Marston L. Ambient particulate matter and health effects: publication bias in studies of short-term associations. Epidemiology. 2005; 16(2):155–163. DOI: 10.1097/01.ede.0000152528.22746.0f. PMID: 15703529.

60. Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA. 2005; 294(18):2330–2335. DOI: 10.1001/jama.294.18.2330. PMID: 16278361.

61. Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15(2):401–402. DOI: 10.1158/1055-9965.EPI-05-0836. PMID: 16492937.

62. Becher H. The concept of residual confounding in regression models and some applications. Stat Med. 1992; 11(13):1747–1758. DOI: 10.1002/sim.4780111308. PMID: 1485057.

63. Brenner H, Blettner M. Controlling for continuous confounders in epidemiologic research. Epidemiology. 1997; 8(4):429–434. DOI: 10.1097/00001648-199707000-00014. PMID: 9209859.

64. Phillips MR, Yang G, Zhang Y, Wang L, Ji H, Zhou M, et al. Risk factors for suicide in China: a national case-control psychological autopsy study. Lancet. 2002; 360(9347):1728–1736. DOI: 10.1016/S0140-6736(02)11681-3. PMID: 12480425.

65. Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, Hankinson SE, et al. Prospective study of type 2 diabetes mellitus and risk of primary open-angle glaucoma in women. Ophthalmology. 2006; 113(7):1081–1086. DOI: 10.1016/j.ophtha.2006.01.066. PMID: 16757028.

66. Craig SL, Feinstein AR. Antecedent therapy versus detection bias as causes of neoplastic multimorbidity. Am J Clin Oncol. 1999; 22(1):51–56. DOI: 10.1097/00000421-199902000-00013. PMID: 10025381.

67. Rogler LH, Mroczek DK, Fellows M, Loftus ST. The neglect of response bias in mental health research. J Nerv Ment Dis. 2001; 189(3):182–187. DOI: 10.1097/00005053-200103000-00007. PMID: 11277355.

68. Murphy EA. The logic of medicine. Baltimore: Johns Hopkins University Press;1976.

69. Sackett DL. Bias in analytic research. J Chronic Dis. 1979; 32(1–2):51–63. DOI: 10.1016/0021-9681(79)90012-2. PMID: 447779.

70. Johannes CB, Crawford SL, McKinlay JB. Interviewer effects in a cohort study: results from the Massachusetts Women’s Health Study. Am J Epidemiol. 1997; 146(5):429–438. DOI: 10.1093/oxfordjournals.aje.a009296. PMID: 9290503.

71. Bloemenkamp KWM, Rosendaal FR, Büller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP, et al. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med. 1999; 159(1):65–70. DOI: 10.1001/archinte.159.1.65. PMID: 9892332.

72. Feinstein AR. Clinical epidemiology: the architecture of clinical research. Philadelphia: W.B. Saunders Company;1985.

73. Yadon ZE, Rodrigues LC, Davies CR, Quigley MA. Indoor and peridomestic transmission of American cutaneous leishmaniasis in northwestern Argentina: a retrospective case-control study. Am J Trop Med Hyg. 2003; 68(5):519–526. DOI: 10.4269/ajtmh.2003.68.519. PMID: 12812336.

74. Anoop S, Saravanan B, Joseph A, Cherian A, Jacob KS. Maternal depression and low maternal intelligence as risk factors for malnutrition in children: a community based case-control study from South India. Arch Dis Child. 2004; 89(4):325–329. DOI: 10.1136/adc.2002.009738. PMID: 15033840. PMCID: PMC1719856.

75. Carlin JB, Doyle LW. Sample size. J Paediatr Child Health. 2002; 38(3):300–304. DOI: 10.1046/j.1440-1754.2002.00855.x. PMID: 12047701.

76. Rigby AS, Vail A. Statistical methods in epidemiology. II: A commonsense approach to sample size estimation. Disabil Rehabil. 1998; 20(11):405–410. DOI: 10.3109/09638289809166102. PMID: 9846240.

77. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet. 2005; 365(9467):1348–1353. DOI: 10.1016/S0140-6736(05)61034-3. PMID: 15823387.

78. Drescher K, Timm J, Jockel KH. The design of case-control studies: the effect of confounding on sample size requirements. Stat Med. 1990; 9(7):765–776. DOI: 10.1002/sim.4780090706. PMID: 2218179.

79. Devine OJ, Smith JM. Estimating sample size for epidemiologic studies: the impact of ignoring exposure measurement uncertainty. Stat Med. 1998; 17(12):1375–1389. DOI: 10.1002/(SICI)1097-0258(19980630)17:12<1375::AID-SIM857>3.3.CO;2-4.

80. Linn S, Levi L, Grunau PD, Zaidise I, Zarka S. Effect measure modification and confounding of severe head injury mortality by age and multiple organ injury severity. Ann Epidemiol. 2007; 17(2):142–147. DOI: 10.1016/j.annepidem.2006.08.004. PMID: 17236984.

81. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using “optimal” cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994; 86(11):829–835. DOI: 10.1093/jnci/86.11.829. PMID: 8182763.

82. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006; 25(1):127–141. DOI: 10.1002/sim.2331. PMID: 16217841.

83. Greenland S. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology. 1995; 6(4):450–454. DOI: 10.1097/00001648-199507000-00025. PMID: 7548361.

84. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999; 28(5):964–974. DOI: 10.1093/ije/28.5.964. PMID: 10597998.

85. MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychol Methods. 2002; 7(1):19–40. DOI: 10.1037/1082-989X.7.1.19. PMID: 11928888.

86. Altman DG. Categorizing continuous variables. In. Armitage P, Colton T, editors. editors. Encyclopedia of biostatistics. 2nd ed. Chichester: John Wiley & Sons;2005. p. p. 708–711. DOI: 10.1002/0470011815.b2a10012.

87. Cohen J. The cost of dichotomization. Appl Psychol Meas. 1983; 7(3):249–253. DOI: 10.1177/014662168300700301.

88. Zhao LP, Kolonel LN. Efficiency loss from categorizing quantitative exposures into qualitative exposures in case-control studies. Am J Epidemiol. 1992; 136:464–474. DOI: 10.1093/oxfordjournals.aje.a116520. PMID: 1415166.

89. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics. 1968; 24(2):295–313. DOI: 10.2307/2528036. PMID: 5683871.

90. Clayton D, Hills M. Models for dose-response. In. Clayton D, Hills M, editors. editors. Statistical models in epidemiology. Oxford: Oxford University Press;1993. p. p. 249–260.

91. Cox DR. Note on grouping. J Am Stat Assoc. 1957; 52(280):543–547. DOI: 10.1080/01621459.1957.10501411.

92. Il’yasova D, Hertz-Picciotto I, Peters U, Berlin JA, Poole C. Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control. 2005; 16(4):383–388. DOI: 10.1007/s10552-004-5025-x. PMID: 15953980.

93. Berglund A, Alfredsson L, David Cassidy J, Jensen I, Nygren A. The association between exposure to a rear-end collision and future neck or shoulder pain: a cohort study. J Clin Epidemiol. 2000; 53(11):1089–1094. DOI: 10.1016/S0895-4356(00)00225-0. PMID: 11106881.

94. Slama R, Werwatz A. Controlling for continuous confounding factors: non- and semiparametric approaches. Rev Epidemiol Sante Publique. 2005; 53(2S):65–80. DOI: 10.1016/S0398-7620(05)84769-8.

95. Greenland S. Introduction to regression modelling. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 401–432.

96. Douglas Thompson W. Statistical analysis of case-control studies. Epidemiol Rev. 1994; 16(1):33–50. DOI: 10.1093/oxfordjournals.epirev.a036143. PMID: 7925726.

97. Schlesselman JJ. Logistic regression for case-control studies. In. Schlesselman JJ, editor. editor. Case-control studies: design, conduct, analysis. Oxford: Oxford University Press;1982. p. p. 235–241.

98. Clayton D, Hills M. Choice and interpretation of models. In. Clayton D, Hills M, editors. editors. Statistical models in epidemiology. Oxford: Oxford University Press;1993. p. p. 271–281.

99. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J. 1983; 286(6376):1489–1493. DOI: 10.1136/bmj.286.6376.1489. PMID: 6405856. PMCID: PMC1547706.

100. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med. 1997; 336(4):309–315. DOI: 10.1056/NEJM199701233360422. PMID: 8995096.

101. Müllner M, Matthews H, Altman DG. Reporting on statistical methods to adjust for confounding: a cross-sectional survey. Ann Intern Med. 2002; 136(2):122–126. DOI: 10.7326/0003-4819-136-2-200201150-00009. PMID: 11790063.

102. Olsen J, Basso O. Re: residual confounding. Am J Epidemiol. 1999; 149(3):290. DOI: 10.1093/oxfordjournals.aje.a009805. PMID: 9927226.

103. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarød K, Holmen J. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis. 2006; 47(3):396–405. DOI: 10.1053/j.ajkd.2005.11.027. PMID: 16490617.

104. Gøtzsche PC. Believability of relative risks and odds ratios in abstracts: cross sectional study. BMJ. 2006; 333(7561):231–234. DOI: 10.1136/bmj.38895.410451.79. PMID: 16854948. PMCID: PMC1523498.

105. Szklo MF, Nieto J. Communicating results of epidemiologic studies. In. Szklo MF, Nieto J, editors. editors. Epidemiology, beyond the basics. Sudbury: Jones and Bartlett;2000. p. p. 408–430.

106. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006; 332(7540):521–525. DOI: 10.1136/bmj.38693.435301.80. PMID: 16428252. PMCID: PMC1388129.

107. Vach W, Blettner M. Biased estimation of the odds ratio in case-control studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol. 1991; 134(8):895–907. DOI: 10.1093/oxfordjournals.aje.a116164. PMID: 1670320.

108. Little RJ, Rubin DB. A taxonomy of missing-data methods. In. Little RJ, Rubin DB, editors. editors. Statistical analysis with missing data. New York: Wiley;2002. p. p. 19–23. DOI: 10.1002/9781119013563.

109. Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med. 2003; 348(21):2136–2137. DOI: 10.1056/NEJMe030054. PMID: 12761370.

110. Rubin DB. Inference and missing data. Biometrika. 1976; 63(3):581–592. DOI: 10.1093/biomet/63.3.581.

111. Schafer JL. Analysis of incomplete multivariate data. London: Chapman & Hall;1997. DOI: 10.1201/9781439821862.

112. Lipsitz SR, Ibrahim JG, Chen MH, Peterson H. Non-ignorable missing covariates in generalized linear models. Stat Med. 1999; 18(17-18):2435–2448. DOI: 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2435::AID-SIM267>3.0.CO;2-B.

113. Rotnitzky A, Robins J. Analysis of semi-parametric regression models with non-ignorable non-response. Stat Med. 1998; 16(1):81–102. DOI: 10.1002/(SICI)1097-0258(19970115)16:1<81::AID-SIM473>3.0.CO;2-0.

114. Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons;1987. DOI: 10.1002/9780470316696.

115. Barnard J, Meng XL. Applications of multiple imputation in medical studies: from AIDS to NHANES. Stat Methods Med Res. 1999; 8(1):17–36. DOI: 10.1177/096228029900800103. PMID: 10347858.

116. Braitstein P, Brinkhof MWG, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006; 367(9513):817–824. DOI: 10.1016/S0140-6736(06)68337-2. PMID: 16530575.

117. Purandare N, Burns A, Daly KJ, Hardicre J, Morris J, Macfarlane G, et al. Cerebral emboli as a potential cause of Alzheimer’s disease and vascular dementia: case-control study. BMJ. 2006; 332(7550):1119–1124. DOI: 10.1136/bmj.38814.696493.AE. PMID: 16648133. PMCID: PMC1459546.

118. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J. Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens. 2001; 19(10):1717–1725. DOI: 10.1097/00004872-200110000-00004. PMID: 11593090.

119. Lohr SL. Design effects. Sampling: design and analysis. Pacific Grove: Duxbury Press;1999.

120. Dunn NR, Arscott A, Thorogood M. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study. Contraception. 2001; 63(2):65–69. DOI: 10.1016/S0010-7824(01)00172-X. PMID: 11292469.

121. Rothman KJ, Greenland S. Basic methods for sensitivity analysis and external adjustment. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 343–358.

122. Custer B, Longstreth WT Jr, Phillips LE, Koepsell TD, Van Belle G. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer. 2006; 6:152. DOI: 10.1186/1471-2407-6-152. PMID: 16759391. PMCID: PMC1524800.

123. Wakefield MA, Chaloupka FJ, Kaufman NJ, Tracy Orleans C, Barker DC, Ruel EE, et al. Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ. 2000; 321(7257):333–337. DOI: 10.1136/bmj.321.7257.333. PMID: 10926588. PMCID: PMC27448.

124. Greenland S. The impact of prior distributions for uncontrolled confounding and response bias: a case study of the relation of wire codes and magnetic fields to childhood leukemia. J Am Stat Assoc. 2003; 98(461):47–54. DOI: 10.1198/01621450338861905.

125. Lash TL, Fink AK. Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology. 2003; 14(4):451–458. DOI: 10.1097/01.EDE.0000071419.41011.cf. PMID: 12843771.

126. Phillips CV. Quantifying and reporting uncertainty from systematic errors. Epidemiology. 2003; 14(4):459–466. DOI: 10.1097/01.ede.0000072106.65262.ae. PMID: 12843772.

127. Cornfield J, Haenszel W, Cuyler Hammond E, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. J Natl Cancer Inst. 1959; 22(1):173–203. DOI: 10.1093/jnci/22.1.173.

128. Langholz B. Factors that explain the power line configuration wiring code–childhood leukemia association: what would they look like? Bioelectromagnetics. 2001; 22(S5):S19–S31. DOI: 10.1002/1521-186X(2001)22:5+<::AID-BEM1021>3.3.CO;2-9. PMID: 11170115.

129. Eisner MD, Smith AK, Blanc PD. Bartenders’ respiratory health after establishment of smoke-free bars and taverns. JAMA. 1998; 280(22):1909–1914. DOI: 10.1001/jama.280.22.1909. PMID: 9851475.

130. Dunne MP, Martin NG, Bailey JM, Heath AC, Bucholz KK, Madden PA, et al. Participation bias in a sexuality survey: psychological and behavioural characteristics of responders and non-responders. Int J Epidemiol. 1997; 26(4):844–854. DOI: 10.1093/ije/26.4.844. PMID: 9279618.

131. Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol. 1999; 28(4):631–639. DOI: 10.1093/ije/28.4.631. PMID: 10480689.

132. Cnattingius S, Zack M, Ekbom A, Gunnarskog J, Linet M, Adami HO. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biomarkers Prev. 1995; 4(5):441–445.

133. z J. Non-response bias as a likely cause of the association between young maternal age at the time of delivery and the risk of cancer in the offspring. Paediatr Perinat Epidemiol. 2003; 17(1):106–112. DOI: 10.1046/j.1365-3016.2003.00460.x. PMID: 12562478.

134. Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD. Response rates among control subjects in case-control studies. Ann Epidemiol. 1995; 5(3):245–249. DOI: 10.1016/1047-2797(94)00113-8. PMID: 7606315.

135. Schulz KF, Grimes DA. Case-control studies: research in reverse. Lancet. 2002; 359(9304):431–434. DOI: 10.1016/S0140-6736(02)07605-5. PMID: 11844534.

136. Olson SH, Voigt LF, Begg CB, Weiss NS. Reporting participation in case-control studies. Epidemiology. 2002; 13(2):123–126. DOI: 10.1097/00001648-200203000-00004. PMID: 11880750.

137. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006; 163(3):197–203. DOI: 10.1093/aje/kwj036. PMID: 16339049.

138. Olson SH. Reported participation in case-control studies: changes over time. Am J Epidemiol. 2001; 154(6):574–581. DOI: 10.1093/aje/154.6.574. PMID: 11549563.

139. Sandler DP. On revealing what we’d rather hide: the problem of describing study participation. Epidemiology. 2002; 13(2):117. DOI: 10.1097/00001648-200203000-00001. PMID: 11880747.

140. Hepworth SJ, Schoemaker MJ, Muir KR, Swerdlow AJ, van Tongeren MJA, McKinney PA. Mobile phone use and risk of glioma in adults: case-control study. BMJ. 2006; 332(7546):883–887. DOI: 10.1136/bmj.38720.687975.55. PMID: 16428250. PMCID: PMC1440611.

141. Hay AD, Wilson A, Fahey T, Peters TJ. The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract. 2003; 20(6):696–705. DOI: 10.1093/fampra/cmg613. PMID: 14701895.

142. Egger M, Jüni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA. 2001; 285(15):1996–1999. DOI: 10.1001/jama.285.15.1996. PMID: 11308437.

143. Osella AR, Misciagna G, Guerra VM, Chiloiro M, Cuppone R, Cavallini A, et al. Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. Int J Epidemiol. 2000; 29(5):922–927. DOI: 10.1093/ije/29.5.922. PMID: 11034979.

144. Dales LG, Ury HK. An improper use of statistical significance testing in studying covariables. Int J Epidemiol. 1978; 7(4):373–376. DOI: 10.1093/ije/7.4.373. PMID: 744677.

145. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993; 138(11):923–936. DOI: 10.1093/oxfordjournals.aje.a116813. PMID: 8256780.

146. Tanis BC, van den Bosch MAAJ, Kemmeren JM, Cats VM, Helmerhorst FM, Algra A, et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001; 345(25):1787–1793. DOI: 10.1056/NEJMoa003216. PMID: 11752354.

147. Rothman KJ, Greenland S. Precision and validity in epidemiologic studies. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 120–125.

148. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet. 2002; 359(9314):1309–1310. DOI: 10.1016/S0140-6736(02)08272-7. PMID: 11965278.

149. Qiu C, Fratiglioni L, Karp A, Winblad B, Bellander T. Occupational exposure to electromagnetic fields and risk of Alzheimer’s disease. Epidemiology. 2004; 15(6):687–694. DOI: 10.1097/01.ede.0000142147.49297.9d. PMID: 15475717.

150. Kengeya-Kayondo JF, Kamali A, Nunn AJ, Ruberantwari A, Wagner HUH, Mulder DW. Incidence of HIV-1 infection in adults and socio-demographic characteristics of seroconverters in a rural population in Uganda: 1990–1994. Int J Epidemiol. 1996; 25(5):1077–1082. DOI: 10.1093/ije/25.5.1077. PMID: 8921497.

151. Mastrangelo G, Fedeli U, Fadda E, Valentini F, Agnesi R, Magarotto G, et al. Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake. Environ Health Perspect. 2004; 112(11):1188–1192. DOI: 10.1289/ehp.6972. PMID: 15289165. PMCID: PMC1247480.

152. Salo PM, Arbes SJ Jr, Sever M, Jaramillo R, Cohn RD, London SJ, et al. Exposure to Alternaria alternata in US homes is associated with asthma symptoms. J Allergy Clin Immunol. 2006; 118(4):892–898. DOI: 10.1016/j.jaci.2006.07.037. PMID: 17030243. PMCID: PMC2080575.

153. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet. 2002; 359(9318):1686–1689. DOI: 10.1016/S0140-6736(02)08594-X. PMID: 12020548.

154. Sasieni P. A note on the presentation of matched case-control data. Stat Med. 1992; 11(5):617–620. DOI: 10.1002/sim.4780110506. PMID: 1594804.

155. Lee GM, Neutra RR, Hristova L, Yost M, Hiatt RA. A nested case-control study of residential and personal magnetic field measures and miscarriages. Epidemiology. 2002; 13(1):21–31. DOI: 10.1097/00001648-200201000-00005. PMID: 11805582.

156. Tiihonen J, Walhbeck K, Lönnqvist J, Klaukka T, Ioannidis JPA, Volavka J, et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ. 2006; 333(7561):224. DOI: 10.1136/bmj.38881.382755.2F. PMID: 16825203. PMCID: PMC1523484.

157. Christenfeld NJ, Sloan RP, Carroll D, Greenland S. Risk factors, confounding, and the illusion of statistical control. Psychosom Med. 2004; 66(6):868–875. DOI: 10.1097/01.psy.0000140008.70959.41. PMID: 15564351.

158. Smith GD, Phillips A. Declaring independence: why we should be cautious. J Epidemiol Community Health. 1990; 44(4):257–258. DOI: 10.1136/jech.44.4.257. PMID: 2277244. PMCID: PMC1060665.

159. Greenland S, Neutra R. Control of confounding in the assessment of medical technology. Int J Epidemiol. 1980; 9(4):361–367. DOI: 10.1093/ije/9.4.361. PMID: 7203778.

160. Robins JM. Data, design, and background knowledge in etiologic inference. Epidemiology. 2001; 12(3):313–320. DOI: 10.1097/00001648-200105000-00011. PMID: 11338312.

161. Sagiv SK, Tolbert PE, Altshul LM, Korrick SA. Organochlorine exposures during pregnancy and infant size at birth. Epidemiology. 2007; 18(1):120–129. DOI: 10.1097/01.ede.0000249769.15001.7c. PMID: 17179760.

162. World Health Organization [WHO]. Body mass index (BMI) [Internet]. Geneva (CH): WHO;c2007; [cited 2007 Sep 10]. Available from. http://www.euro.who.int/nutrition/20030507_1.

163. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003; 362(9382):419–427. DOI: 10.1016/S0140-6736(03)14065-2. PMID: 12927427.

164. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965; 58(5):295–300. DOI: 10.1177/003591576505800503.

165. Vineis P. Causality in epidemiology. Soz Praventiv Med. 2003; 48(2):80–87. DOI: 10.1007/s00038-003-1029-7. PMID: 12841079.

166. Empana JP, Ducimetière P, Arveiler D, Ferrières J, Evans A, Ruidavets JB, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J. 2003; 24(21):1903–1911. DOI: 10.1016/j.ehj.2003.09.002. PMID: 14585248.

167. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Lancet. 1999; 353:1547–1557. DOI: 10.1016/S0140-6736(99)04021-0. PMID: 10334252.

168. Cambien F, Chretien JM, Ducimetiere P, Guize L, Richard JL. Is the relationship between blood pressure and cardiovascular risk dependent on body mass index? Am J Epidemiol. 1985; 122(3):434–442. DOI: 10.1093/oxfordjournals.aje.a114124. PMID: 4025293.

169. Hosmer DW, Taber S, Lemeshow S. The importance of assessing the fit of logistic regression models: a case study. Am J Public Health. 1991; 81(12):1630–1635. DOI: 10.2105/AJPH.81.12.1630. PMID: 1746660. PMCID: PMC1405276.

170. Tibshirani R. A plain man’s guide to the proportional hazards model. Clin Invest Med. 1982; 5(1):63–68.

171. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998; 88(1):15–19. DOI: 10.2105/AJPH.88.1.15. PMID: 9584027. PMCID: PMC1508384.

172. Uter W, Pfahlberg A. The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res. 2001; 10(3):231–237. DOI: 10.1177/096228020101000305. PMID: 11446150.

173. Schwartz LM, Woloshin S, Dvorin EL, Gilbert Welch H. Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks. BMJ. 2006; 333(7581):1248. DOI: 10.1136/bmj.38985.564317.7C. PMID: 17060338. PMCID: PMC1702463.

174. Nakayama T, Zaman MM, Tanaka H. Reporting of attributable and relative risks, 1966-97. Lancet. 1998; 351(9110):1179. DOI: 10.1016/S0140-6736(05)79123-6. PMID: 9643696.

175. Cornfield J. A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst. 1951; 11(6):1269–1275.

176. Pearce N. What does the odds ratio estimate in a case-control study? Int J Epidemiol. 1993; 22(6):1189–1192. DOI: 10.1093/ije/22.6.1189. PMID: 8144304.

177. Rothman KJ, Greenland S. Measures of disease frequency. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 44–45.

178. Doll R, Bradford Hill A. The mortality of doctors in relation to their smoking habits: a preliminary report. 1954. Br Med J. 2004; 328(7455):1529–1533. DOI: 10.1136/bmj.328.7455.1529. PMID: 15217868. PMCID: PMC437141.

179. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003; 362(9387):847–852. DOI: 10.1016/S0140-6736(03)14338-3. PMID: 13678970.

180. Greenland S. Applications of stratified analysis methods. In. Rothman KJ, Greenland S, editors. editors. Modern epidemiology. 2nd ed. New York: Lippincott Raven;1998. p. p. 295–297.

181. Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001; 30(3):427–432. DOI: 10.1093/ije/30.3.427. PMID: 11416056.

182. Vandenbroucke JP, Koster T, Rosendaal FR, Briët E, Reitsma PH, Bertina RM. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994; 344(8935):1453–1457. DOI: 10.1016/S0140-6736(94)90286-0. PMID: 7968118.

183. Botto LD, Khoury MJ. Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol. 2001; 153(10):1016–1020. DOI: 10.1093/aje/153.10.1016. PMID: 11384958.

184. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004; 141(10):764–770. DOI: 10.7326/0003-4819-141-10-200411160-00007. PMID: 15545676.

185. Martinelli I, Taioli E, Battaglioli T, Podda GM, Passamonti SM, Pedotti P, et al. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med. 2003; 163(22):2771–2774. DOI: 10.1001/archinte.163.22.2771. PMID: 14662632.

186. Kyzas PA, Loizou KT, Ioannidis JPA. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005; 97(14):1043–1055. DOI: 10.1093/jnci/dji184. PMID: 16030302.

187. Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980; 112(4):467–470. DOI: 10.1093/oxfordjournals.aje.a113015. PMID: 7424895.

188. Saracci R. Interaction and synergism. Am J Epidemiol. 1980; 112(4):465–466. DOI: 10.1093/oxfordjournals.aje.a113014. PMID: 7424894.

189. Rothman KJ. Epidemiology: an introduction. Oxford: Oxford University Press;2002.

190. Rothman KJ. Interactions between causes. Modern epidemiology. Boston: Little Brown;1986.

191. Hess DR. How to write an effective discussion. Respir Care. 2004; 49(10):1238–1241.

192. Horton R. The hidden research paper. JAMA. 2002; 287(21):2775–2778. DOI: 10.1001/jama.287.21.2775. PMID: 12038909.

193. Horton R. The rhetoric of research. BMJ. 1995; 310(6985):985–987. DOI: 10.1136/bmj.310.6985.985. PMID: 7728037. PMCID: PMC2549363.

194. Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ. 1999; 318(7193):1224–1225. DOI: 10.1136/bmj.318.7193.1224. PMID: 10231230. PMCID: PMC1115625.

195. Perneger TV, Hudelson PM. Writing a research article: advice to beginners. Int J Qual Health Care. 2004; 16(3):191–192. DOI: 10.1093/intqhc/mzh053. PMID: 15150149.

196. Annals of Internal Medicine. Information for authors [Internet]. Philadelphia (PA): American College of Physicians;c2007; [cited 2007 Sep 10]. Available from. http://www.annals.org/shared/author_info.html.

197. Maldonado G, Poole C. More research is needed. Ann Epidemiol. 1999; 9(1):17–18.

198. Phillips CV. The economics of ‘more research is needed’. Int J Epidemiol. 2001; 30(4):771–776. DOI: 10.1093/ije/30.4.771. PMID: 11511601.

199. Winkleby MA, Kraemer HC, Ahn DK, Varady AN. Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA. 1998; 280(4):356–362. DOI: 10.1001/jama.280.4.356. PMID: 9686553.

200. Galuska DA, Will JC, Serdula MK, Ford ES. Are health care professionals advising obese patients to lose weight? JAMA. 1999; 282(16):1576–1578. DOI: 10.1001/jama.282.16.1576. PMID: 10546698.

201. Spearman C. The proof and measurement of association between two things. Am J Psychol. 1904; 15(1):72–101. DOI: 10.2307/1412159.

202. Fuller WA, Hidiroglou MA. Regression estimation after correcting for attenuation. J Am Stat Assoc. 1978; 73(361):99–104. DOI: 10.1080/01621459.1978.10480011.

203. MacMahon S, Peto R, Collins R, Godwin J, MacMahon S, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990; 335(8692):765–774. DOI: 10.1016/0140-6736(90)90878-9. PMID: 1969518.

204. Phillips AN, Smith GD. How independent are “independent” effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol. 1991; 44(11):1223–1231. DOI: 10.1016/0895-4356(91)90155-3. PMID: 1941017.

205. Phillips AN, Smith GD. Bias in relative odds estimation owing to imprecise measurement of correlated exposures. Stat Med. 1992; 11(7):953–961. DOI: 10.1002/sim.4780110712. PMID: 1604073.

206. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol. 1980; 112(4):564–569. DOI: 10.1093/oxfordjournals.aje.a113025. PMID: 7424903.

207. Poole C, Peters U, Il’yasova D, Arab L. Commentary: this study failed? Int J Epidemiol. 2003; 32(4):534–535. DOI: 10.1093/ije/dyg197. PMID: 12913024.

208. Kaufman JS, Cooper RS, McGee DL. Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997; 8(6):621–628. DOI: 10.1097/00001648-199711000-00006. PMID: 9345660.

209. Greenland S. Randomization, statistics, and causal inference. Epidemiology. 1990; 1(6):421–429. DOI: 10.1097/00001648-199011000-00003. PMID: 2090279.

210. Taubes G. Epidemiology faces its limits: the search for subtle links between diet, lifestyle, or environmental factors and disease is an unending source of fear—but often yields little certainty. Science. 1995; 269(5221):164–169. DOI: 10.1126/science.7618077. PMID: 7618077.

211. Temple R. Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance. JAMA. 1999; 281(9):841–844. DOI: 10.1001/jama.281.9.841. PMID: 10071007.

212. Greenberg RS, Shuster JL Jr. Epidemiology of cancer in children. Epidemiol Rev. 1985; 7(1):22–48. DOI: 10.1093/oxfordjournals.epirev.a036284. PMID: 3902495.

213. Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, Lazovich D, et al. Prospective study of diet and ovarian cancer. Am J Epidemiol. 1999; 149(1):21–31. DOI: 10.1093/oxfordjournals.aje.a009723. PMID: 9883790.

214. Kemmeren JM, Algra A, Meijers JCM, Tans G, Bouma BN, Curvers J, et al. Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V_Leiden mutation: a randomized trial. Blood. 2004; 103(3):927–933. DOI: 10.1182/blood-2003-04-1285. PMID: 14551147.

215. Egger M, May M, Chêne G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002; 360(9327):119–129. DOI: 10.1016/S0140-6736(02)09411-4. PMID: 12126821.

216. Campbell DT. Factors relevant to the validity of experiments in social settings. Psychol Bull. 1957; 54(4):297–312. DOI: 10.1037/h0040950. PMID: 13465924.

217. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999; 130(6):515–524. DOI: 10.7326/0003-4819-130-6-199903160-00016. PMID: 10075620.

218. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics. 2001; 7(2):205–218. DOI: 10.1007/s11948-001-0041-7. PMID: 11349360.

219. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003; 289(4):454–465. DOI: 10.1001/jama.289.4.454. PMID: 12533125.

220. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med. 1986; 1(3):155–158. DOI: 10.1007/BF02602327. PMID: 3772583.

221. Stelfox HT, Chua G, O’Rourke K, Detsky AS. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998; 338(2):101–106. DOI: 10.1056/NEJM199801083380206. PMID: 9420342.

222. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003; 326(7400):1167–1170. DOI: 10.1136/bmj.326.7400.1167. PMID: 12775614. PMCID: PMC156458.

223. Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA. 2003; 290(7):921–928. DOI: 10.1001/jama.290.7.921. PMID: 12928469.

224. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998; 279(19):1566–1570. DOI: 10.1001/jama.279.19.1566. PMID: 9605902.

225. Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996; 21(3):515–542. DOI: 10.1215/03616878-21-3-515. PMID: 8784687.

226. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J. Looking through a keyhole at the tobacco industry: the Brown and Williamson documents. JAMA. 1995; 274(3):219–224. DOI: 10.1001/jama.1995.03530030039032. PMID: 7609230.

227. Huss A, Egger M, Hug K, Huwiler-Müntener K, Röösli M. Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies. Environ Health Perspect. 2007; 115(1):1–4. DOI: 10.1289/ehp.9149. PMID: 17366811. PMCID: PMC1797826.

228. Safer DJ. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis. 2002; 190(9):583–592. DOI: 10.1097/00005053-200209000-00002. PMID: 12357091.

229. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ. 1995; 311(7009):844–846. DOI: 10.1136/bmj.311.7009.844. PMID: 7580491. PMCID: PMC2550853.

230. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004; 291(20):2457–2465. DOI: 10.1001/jama.291.20.2457. PMID: 15161896.

231. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ. 2003; 326(7400):1171–1173. DOI: 10.1136/bmj.326.7400.1171. PMID: 12775615. PMCID: PMC156459.

232. Scherer RW, Langenberg P, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev. 2007; (2):MR000005. DOI: 10.1002/14651858.MR000005.pub3. PMCID: PMC7437388.

233. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001; 357(9263):1191–1194. DOI: 10.1016/S0140-6736(00)04337-3.

234. Stroup DF, Berlin JA, Morton SC, Olkin I, David Williamson G, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000; 283(15):2008–2012. DOI: 10.1001/jama.283.15.2008. PMID: 10789670.

235. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001; 134(8):663–694. DOI: 10.7326/0003-4819-134-8-200104170-00012. PMID: 11304107.

236. Moher D. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. JAMA. 1998; 279(18):1489–1491. DOI: 10.1001/jama.279.18.1489. PMID: 9600488.

237. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA. 1996; 276(8):637–639. DOI: 10.1001/jama.1996.03540080059030. PMID: 8773637.